Clinical software maker MedAssets (MDAS) popped more than 30% Monday after the company agreed to be acquired by privately held Pamplona Capital for $2.7 billion. Pamplona said that it will combine MedAssets’ revenue cycle management (i.e. billing) software with another company already in its portfolio, called Precyse. “MedAssets and Precyse already have a strategic partnership and share a number of customers, and their offerings are highly
MedAssets (MDAS) stock got a lift Wednesday after the medical software maker announced plans to cut 5% of its workforce, or roughly 180 jobs, by year’s end. MedAssets stock was up 4.5% in afternoon trading in the stock market today, near 20. On Tuesday, shares touched a nearly six-month low, below 19. MedAssets expects restructuring expenses of $11 million, with $5 million of that to be recorded in the third quarter and the remainder in Q4. The
Health care software maker (MDAS) beat what an analyst called low expectations; its outlook also exceeded Wall Street views, sending the stock gapping up to a 12-month high. MedAssets stock was up 8.5% in midday trading in the stock market today, above 23. Earlier, shares rose as high as 23.85. Late Wednesday, MedAssets posted earnings per share minus items of 31 cents, a penny above Q2 2014 and 4 cents better than the consensus estimate of